Neuro HK, s.r.o. POLIKLINIKA CHOCEŇ, a.s.

Choceň 565 01

0 studies enrolling now · 1 studies all time

What they study most

Alzheimer Disease

Studies at this site

• Proof-of-Concept Study of a Selective p38 MAPK Alpha Inhibitor, Neflamapimod, in Subjects With Mild Alzheimer's Disease — Completed